This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Zurich. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Michele Bernasconi: Innovator in Cancer Therapies
Introduction
Michele Bernasconi is a notable inventor based in Zollikon, Switzerland. He has made significant contributions to the field of cancer therapies through his innovative work on single domain antibodies. His research is pivotal in advancing treatment options for cancer patients.
Latest Patents
Michele Bernasconi holds a patent for "Single Domain Antibodies and Their Use in Cancer Therapies." This patent represents a significant advancement in the development of targeted therapies for cancer, showcasing his commitment to improving patient outcomes.
Career Highlights
Bernasconi is affiliated with the University of Zurich, where he continues to engage in groundbreaking research. His work at this prestigious institution allows him to collaborate with other leading scientists and contribute to the academic community.
Collaborations
Michele has worked alongside talented colleagues, including Nagjie Laila Alijaj and Sandrine Moutel. These collaborations enhance the research environment and foster innovation in the field of cancer therapies.
Conclusion
Michele Bernasconi's contributions to cancer therapy through his patent and research at the University of Zurich highlight his role as an influential inventor. His work continues to inspire advancements in medical science and improve the lives of many.